• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

XOMA Royalty Corporation - Common Stock (NQ:XOMA)

26.07 -0.67 (-2.51%)
Streaming Delayed Price Updated: 12:35 PM EST, Feb 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,543
Open 26.94
Bid (Size) 25.89 (100)
Ask (Size) 26.12 (100)
Prev. Close 26.74
Today's Range 25.85 - 26.94
52wk Range 18.35 - 39.92
Shares Outstanding 11,782,723
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
XOMA Royalty to Present at Investor Conferences in March
February 18, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
February 09, 2026
Generation Bio Stockholders Received $4.2913 Per Share in Cash Plus a Contingent Value Right 
From XOMA Royalty Corporation
Via GlobeNewswire

Performance

YTD
-6.9%
-6.9%
1 Month
+1.1%
+1.1%
3 Month
-19.3%
-19.3%
6 Month
-22.6%
-22.6%
1 Year
+12.9%
+12.9%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
January 20, 2026
From Pomerantz LLP
Via GlobeNewswire
LAVA Therapeutics Stock Slips 9% Pre-Market – Here’s Why The Company Canceled Its Shareholder Meeting ↗
September 30, 2025
Via Stocktwits
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
XOMA Royalty Announces CFO Transition
January 12, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
Unusual volume stocks in Wednesday's session ↗
January 07, 2026
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
January 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
December 30, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
December 30, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Declares Quarterly Preferred Stock Dividends
December 22, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Enters into Agreement to Acquire Generation Bio
December 15, 2025
From Generation Bio Co.; XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Corporation: A Deep Dive into a Biotech Royalty Aggregator (12/13/2025)
December 13, 2025
Via PredictStreet
Topics Intellectual Property
News headline image
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
December 05, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition
December 05, 2025
From Mural Oncology plc
Via GlobeNewswire
News headline image
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty
November 26, 2025
From Mural Oncology plc
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
November 21, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
November 12, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
October 24, 2025
From Mural Oncology plc
Via GlobeNewswire
News headline image
LAVA Therapeutics Stock Drops After Amended Deal With XOMA Royalty ↗
October 17, 2025
Via Stocktwits
News headline image
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
October 17, 2025
From XOMA Royalty Corporation; LAVA Therapeutics N.V.
Via GlobeNewswire
News headline image
Turnstone Biologics: A $100 Dream Collides with a $0.34 Reality
October 17, 2025
Via MarketMinute
Topics Intellectual Property Workforce
News headline image
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
October 02, 2025
From XOMA Royalty Corporation; LAVA Therapeutics
Via GlobeNewswire
News headline image
XOMA Royalty Declares Quarterly Preferred Stock Dividends
September 22, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
September 17, 2025
From XOMA Royalty Corporation
Via GlobeNewswire

Frequently Asked Questions

Is XOMA Royalty Corporation - Common Stock publicly traded?
Yes, XOMA Royalty Corporation - Common Stock is publicly traded.
What exchange does XOMA Royalty Corporation - Common Stock trade on?
XOMA Royalty Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for XOMA Royalty Corporation - Common Stock?
The ticker symbol for XOMA Royalty Corporation - Common Stock is XOMA on the Nasdaq Stock Market
What is the current price of XOMA Royalty Corporation - Common Stock?
The current price of XOMA Royalty Corporation - Common Stock is 26.07
When was XOMA Royalty Corporation - Common Stock last traded?
The last trade of XOMA Royalty Corporation - Common Stock was at 02/26/26 12:35 PM ET
What is the market capitalization of XOMA Royalty Corporation - Common Stock?
The market capitalization of XOMA Royalty Corporation - Common Stock is 307.18M
How many shares of XOMA Royalty Corporation - Common Stock are outstanding?
XOMA Royalty Corporation - Common Stock has 307M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap